Status:
UNKNOWN
Childhood Adiposity and Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes (CONCEPTT Kids)
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
SRI International
Juvenile Diabetes Research Foundation
Conditions:
Neurologic Disorder
Adiposity
Eligibility:
All Genders
3-7 years
Brief Summary
This is a follow-up study of children born to mothers who participated in the CONCEPTT Trial. CONCEPTT (a multicentre randomized controlled trial of continuous glucose monitoring (CGM) in women with T...
Detailed Description
The assessments will occur between the children's ages of 3-7 years. The assessment will include obtaining consent and child measurements including weight, height, waist circumference and skinfold thi...
Eligibility Criteria
Inclusion
- Children of women who participated in the CONCEPTT trial at selected recruiting sites.
Exclusion
- Children (of women who participated in the CONCEPTT trial) with major congenital anomalies will be assessed on a case by case basis to determine eligibility.
Key Trial Info
Start Date :
September 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT04098679
Start Date
September 30 2019
End Date
December 31 2023
Last Update
October 3 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada, T2T 5C7
2
Lawson Health Research Institute
London, Ontario, Canada
3
Mount Sinai Hospital
Toronto, Ontario, Canada
4
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada